Michael O'Dwyer to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Michael O'Dwyer has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.239
-
Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma. N Engl J Med. 2019 05 30; 380(22):2104-2115.
Score: 0.127
-
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL. Leuk Lymphoma. 2018 06; 59(6):1338-1347.
Score: 0.113